Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-07-10
1999-06-22
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514182, 514255, 514315, 514396, 544224, 544388, 546195, 5483355, 548336, 548529, 552641, 552622, 552633, A61K 3156, C07J 100
Patent
active
059143240
ABSTRACT:
6-hydroxy and 6-oxo-androstane derivatives of formula (I), active on the cardiovascular system. ##STR1## wherein: the symbol A represents CH--OR, C.dbd.N--OR, CH--CH.dbd.N--OR and C.dbd.CH--N--OR; and R.sup.1, R.sup.2 and R.sup.3 are as defined herein.
REFERENCES:
patent: 2863885 (1958-12-01), Babcock
patent: 3646064 (1972-02-01), Anner et al.
patent: 5444055 (1995-08-01), Cerri et al.
patent: 5583127 (1996-12-01), Cerri et al.
Sergio Bova, et al., Hypertension, vol. 17, No. 6, pp. 944-950, "Effects of an Endogenous Quabainlike Compound on Heart and Aorta", Jun. 1991.
Fabio Celotti, et al., J. Steroid Biochem., vol. 18, No. 4, pp. 397-401, "Effects of 6- and 7-Hydroxy Metabolites of 3.beta., 17.beta.-Dihydroxy-5.alpha.-Androstane on Gonadotrophin and Prolactin Secretion and on Sex Accessories Weight of Male Rats", 1983.
H. J. G. M. Derks, et al., Steroids, vol. 31, No. 2, pp. 289-290 and 302-304, "The Indentification and Quanitification of Three New 6.alpha.-Hydroxylated Corticosteroids in Human Neonatal Urine", Feb. 1978.
Peter H. Jellinck, et al., J. Steroid Biochem. Molec. Biol., vol. 39 , No. 6, pp. 947-951, "Suppression of 5.alpha.-Androstane-3.beta., 17.beta.-Diol Hydroxylase Activity in Rat Pituitary by Cobalt Protoporhyrin: Implications for Testosterone Homeostasis", 1991.
Susumu Miyabo, et al., Folia Endocrinol. Jap., vol. 52, pp. 630-636, "Cortisol Metabolites in Human and Dog Plasma a Comparative Study", 1976, (with partial English translation).
John Orlowski, et al., Endocrinology, vol. 128, No. 2, pp. 872-884, "Epithelial-Stromal Interactions in The Regulation of Rat Ventral Prostate Function: Indentification and Characterization of Pathways for Androgen Metabolism in Isolated Cell Types", 1991.
Kenneth D. R. Setchell, FEBS Letters, vol. 70 , No. 1, pp. 197-200, "6-Hydroxylation, an Important Route in the Metabolism of Corticosteroids by the Baboon: The Fate of Administered Tetrahydrocortisol", Nov. 1976.
John. F. Templeton, et al., J. Chem. Soc. Perkin Trans., vol. 1, pp. 1361-1368, "Synthesis of Ring-A and -B Substituted 17.alpha.-Acetoxypregnan-20-One Derivatives with Potential Activity on the Digital Receptor in Cardiac Muscle", 1987.
John. F. Templeton, et al., Steroids, vol. 49, pp. 383-396, "Structure-Activity Relationships of Progesterone Derivatives that bind to the Digitals Receptor: Modifications in A and B Rings", Apr.-May 1987.
Chemical Abstracts, vol. 114, p. 89, AN-136215d, 1991.
Chemical Abstracts, vol. 109, p. 68, AN-17146u, 1988.
Chemical Abstracts, vol. 119, p. 1037, AN-271486m, 1993.
Chemical Abstracts, vol. 116, p. 87, AN-99567p, 1992.
De Munari Sergio
Folpini Elena
Frigerio Marco
Melloni Piero
Serra Fulvio
Jones Dwayne C.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
6-Hydroxy and 6-oxo-androstane derivatives active on the cardiov does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-Hydroxy and 6-oxo-androstane derivatives active on the cardiov, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-Hydroxy and 6-oxo-androstane derivatives active on the cardiov will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1708239